ICON Public Limited Company (ICLR) Stock Analysis & Investment Frameworks
ICON Public Limited Company (ICLR) stock analysis on Invetso. Review ICON Public Limited Company’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
ICON Public Limited Company Company Overview
- Exchange: NASDAQ
- Sector: Healthcare
- Industry: Medical - Diagnostics & Research
- Country: IE
ICON Public Limited Company Key Financial Metrics
- Market Cap: $15.34B
- Revenue: $8.25B
- P/E Ratio: 66.91
- ROE: 4.85%
- ROIC: 4.85%
- Dividend Yield: N/A
About ICON Public Limited Company
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company has a strategic alliance with Advarra, Inc. for the development of a connected, research-ready clinical trial site network model. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.
ICON Public Limited Company Investment Frameworks
Invetso analyzes ICON Public Limited Company (ICLR) across the following frameworks:
- ICON Public Limited Company 10Y Growth Potential
- ICON Public Limited Company Scenario Analysis
- ICON Public Limited Company Risks & Opportunities
- ICON Public Limited Company Economic Moat
- ICON Public Limited Company Business Model
- ICON Public Limited Company Management
- ICON Public Limited Company SWOT Analysis
- ICON Public Limited Company Porter's 5 Forces
- ICON Public Limited Company PESTLE Analysis
- ICON Public Limited Company ESG Analysis